Evidence map›Paper›PMID 28390055›Full record

ArticleIntensive care medicine experimental2017

Extracorporeal CO

Alexandra G May, Ayan Sen, Matthew E Cove, John A Kellum, William J Federspiel

Open access · goldAbstract read
In one paragraph

Article in Intensive care medicine experimental, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Guideline
  2. COBMC nephrology · 2019
    Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Observational
  8. Review
  9. Article
  10. Review
  11. Suitable COBioengineering (Basel, Switzerland) · 2021
    Article
  12. Article
  13. Article
  14. [Current techniques for extracorporeal decarboxylation].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2019
    Review
  15. Article
  16. Review
  17. Control of respiratory drive by extracorporeal COCritical care (London, England) · 2019
    Article
  18. Modification of Nutrition Therapy During Continuous Renal Replacement Therapy in Critically Ill Pediatric Patients: A Narrative Review and Recommendations.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Alexandra G MayDepartment of Chemical Engineering, University of Pittsburgh, Pittsburgh, PA, USA.
Ayan SenDepartment of Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA.
Matthew E CoveDepartment of Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA.
John A KellumMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
William J FederspielDepartment of Chemical Engineering, University of Pittsburgh, Pittsburgh, PA, USA. wfedersp@pitt.edu.ORCID http://orcid.org/0000-0002-7068-6779
University of Pittsburgh · USMayo Clinic Hospital · USNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCritically ill patients with acute respiratory distress syndrome and acute exacerbations of chronic obstructive pulmonary disease often develop hypercapnia and require mechanical ventilation. Extracorporeal carbon dioxide removal can manage hypercarbia by removing carbon dioxide directly from the bloodstream. Respiratory hemodialysis uses traditional hemodialysis to remove CO

methodsBench studies were performed using a scaled down respiratory hemodialyzer in bovine or porcine blood. The scaling factor for the bench top experiments was 22.5. In vitro dialysate flow rates ranged from 2.2 to 24 mL/min (49.5-540 mL/min scaled up) and blood flow rates were set at 11 and 18.7 mL/min (248-421 mL/min scaled up). Blood inlet CO

resultsResults are reported as scaled up values. The CO

conclusionsWhen the bench top data is scaled up, the system removes a therapeutic amount of CO

Indexed as

ARDSCOPDECCO2RExtracorporeal carbon dioxide removalRespiratory hemodialysis

Identifiers

PMID28390055
PMCPMC5383917
OpenAlexW2605202475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.